• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Cobimetinib Hemifumarate
    1 Drug classified under this active ingredient

    All the Active Ingredient Drugs

    partial basket chart

    Protein Kinase Inhibitor. Cobimetinib Hemifumarate 20 mg.
    F.C. TABS.:63.
    60 mg (3 tabs. of 20 mg) once dly., taken on a 28 day cycle. 
    21 consecutive d.  (1st  -21st day -tmt. period); follow.by a 7-day break (22nd -28th –tmt. break).  Each subseq. tmt. cycle should start after the 7-day tmt. break has elapsed. See lit.
    Indicat.  for use in comb.  with vemurafenib for the tmt. of adult pts. with unresectab. or metastat. melanoma with a BRAF V600 mutation.
    C/I: Hypersens.